125 related articles for article (PubMed ID: 2174763)
1. Activities of serum enzymes in patients with viral hepatitis B, posthepatitic cirrhosis and hepatocellular carcinoma.
Zheng T; Ren ZY
Chin Med J (Engl); 1990 Sep; 103(9):729-34. PubMed ID: 2174763
[TBL] [Abstract][Full Text] [Related]
2. Serum alpha-L-fucosidase activity and tumor size in hepatocellular carcinoma.
Takahashi H; Saibara T; Iwamura S; Tomita A; Maeda T; Onishi S; Yamamoto Y; Enzan H
Hepatology; 1994 Jun; 19(6):1414-7. PubMed ID: 7514563
[TBL] [Abstract][Full Text] [Related]
3. [Value of serum glycosidase spectrum in the diagnosis of hepatocellular carcinoma].
Zhang SM
Zhonghua Zhong Liu Za Zhi; 1992 Mar; 14(2):143-6. PubMed ID: 1319891
[TBL] [Abstract][Full Text] [Related]
4. The clinical significance of serum alpha-L-fucosidase assay in hepatocellular carcinoma.
Yamamoto K; Yanagita T; Watanabe N; Morito F; Ozaki I; Motomura M; Ikuyama S; Setoguchi Y; Fujii S; Kariya T
Fukuoka Igaku Zasshi; 1988 Jun; 79(6):463-8. PubMed ID: 2852632
[No Abstract] [Full Text] [Related]
5. Rapid kinetic rate assay of the serum alpha-L-fucosidase in patients with hepatocellular carcinoma by using a novel substrate.
Wang JJ; Cao EH
Clin Chim Acta; 2004 Sep; 347(1-2):103-9. PubMed ID: 15313147
[TBL] [Abstract][Full Text] [Related]
6. On some glycosidases (beta-D-mannosidase, alpha-L-fucosidase, N-acetyl-beta-D-glucosaminidase) of human seminal plasma.
Ben Ayed S; Gonzales J; Foglietti MJ; Percheron F; Bernard M
Andrologia; 1989; 21(5):432-6. PubMed ID: 2817447
[TBL] [Abstract][Full Text] [Related]
7. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
8. The degradation of glycoconjugates in the human gastric mucous membrane.
Zwierz K; Gindzienski A; Glowacka D; Porowski T
Acta Med Acad Sci Hung; 1981; 38(2):145-52. PubMed ID: 6798808
[TBL] [Abstract][Full Text] [Related]
9. Ornithine decarboxylase activity in the non-cancerous hepatic tissue of patients with hepatocellular carcinoma.
Kubo S; Tamori A; Omura T; Ikebe T; Wakasa K; Hirohashi K; Kinoshita H; Otani S
Hepatogastroenterology; 2000; 47(33):820-3. PubMed ID: 10919038
[TBL] [Abstract][Full Text] [Related]
10. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
11. [Serum arginase activity in patients with liver cirrhosis and hepatocellular carcinoma].
Chrzanowska A; Mielczarek-Puta M; Skwarek A; Krawczyk M; Barańczyk-Kuźma A
Wiad Lek; 2007; 60(5-6):215-8. PubMed ID: 17966882
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and etiologic features of hepatocarcinoma in Sicily].
Carroccio A; Soresi M; Bonfissuto G; Magliarisi C; Anastasi G; Vuturo O; Notarbartolo A; Montalto G
Ann Ital Med Int; 1999; 14(4):233-8. PubMed ID: 10638015
[TBL] [Abstract][Full Text] [Related]
13. [Value of the serum measurement of alpha-L-fucosidase in the diagnosis of hepatocarcinoma].
López Vivancos J; Segura RM; Oliva G; Vives L; Pascual C; Vilaseca J
Med Clin (Barc); 1989 Sep; 93(7):241-3. PubMed ID: 2478845
[TBL] [Abstract][Full Text] [Related]
14. Fucosyltransferases: differential plasma and tissue alterations in hepatocellular carcinoma and cirrhosis.
Hutchinson WL; Du MQ; Johnson PJ; Williams R
Hepatology; 1991 Apr; 13(4):683-8. PubMed ID: 1849114
[TBL] [Abstract][Full Text] [Related]
15. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
[TBL] [Abstract][Full Text] [Related]
16. [Expression of GST-pi and HBV infection in hepatocellular carcinoma].
Shen LJ; Zhang ZJ; Zhang HX; Yang WB; Huang R
Ai Zheng; 2002 Jan; 21(1):29-32. PubMed ID: 12500393
[TBL] [Abstract][Full Text] [Related]
17. Serum and tissue alpha-L-fucosidase activity in the pre-clinical and clinical stages of hepatocellular carcinoma.
Hutchinson WL; Johnson PJ; Du MQ; Williams R
Clin Sci (Lond); 1991 Aug; 81(2):177-82. PubMed ID: 1716188
[TBL] [Abstract][Full Text] [Related]
18. Serum lysyl oxidase activity in chronic liver disease in comparison with serum levels of prolyl hydroxylase and laminin.
Murawaki Y; Kusakabe Y; Hirayama C
Hepatology; 1991 Dec; 14(6):1167-73. PubMed ID: 1683640
[TBL] [Abstract][Full Text] [Related]
19. Reduction of double-stranded RNA-activated protein kinase in hepatocellular carcinoma associated with hepatitis B virus.
Chen GG; Lai PB; Ho RL; Chan PK; Xu H; Wong J; Lau WY
J Med Virol; 2004 Jun; 73(2):187-94. PubMed ID: 15122791
[TBL] [Abstract][Full Text] [Related]
20. [Measurement of serum immunoreactive beta-glucuronidase: a possible serological marker for histological hepatic cell necrosis and to predict the histological progression of hepatitis].
Ohta H
Hokkaido Igaku Zasshi; 1991 Jul; 66(4):545-57. PubMed ID: 1655603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
